AEGiS-BBC: 'Molecular condom' to combat HIV BBC News OnlineImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to BBC News Online main menu
DonateNow
Print this article

'Molecular condom' to combat HIV

BBC News - December 31, 2006


A "molecular condom" to protect women against HIV is being developed by US scientists.

The liquid formulated by a University of Utah team turns into a gel-like coating when inserted into the vagina.

Then, when exposed to semen, it returns to liquid form and releases an anti-viral drug to attack HIV.

However, the technology, featured in the Journal of Pharmaceutical Sciences, is still around five years away from being tested in humans.

And the researchers predict it will be around 10 years before it might be in widespread use.

Researcher Dr Patrick Kiser said: "The ultimate hope for this technology is to protect women and their unborn or nursing children from the Aids virus."

The Utah project is part of a worldwide research effort to develop "microbicides" - drug-delivery systems such as gels, rings, sponges or creams to prevent infection by HIV and other sexually transmitted diseases.

They are seen as a way for women to gain power by protecting themselves from HIV, particularly in impoverished nations where Aids is widespread, where rape is rampant, or, where conventional condoms are taboo, not reliably available or where men resist using them.

Short-term effect

First-generation microbicides now being tested are expected to be available within four years and to be 50-60% effective.

However, Dr Kiser said they lasted only for a short time, meaning they had to be used shortly before sex.

The potential advantage of his technology is that it would be much longer lasting.

"We're shooting for a microbicide delivery system that would be used once a day or once a month," he said.

Tests have already shown that their 'hydrogel' is unlikely to cause significant side effects, or discomfort.

It is designed not to dehydrate vaginal cells, which can trigger infections, and not to be diluted by other fluids.

The next stage will be to see whether anti-viral drugs incorporated into the hydrogel can be released with the same efficiency as in the lab.

Indeed the researchers are hopeful that because the gel would be much thinner inside a woman than it was in the lab tests, the release of drugs should be even more effective.

High hopes

Yusef Azad, of the National Aids Trust, said: "Millions of women currently have little control over their sexual health and microbicides could put the power of preventing HIV into women's hands.

"It is vitally important that sufficient funding is channelled into the development of effective microbicides so that women have a range of options of products such as gels, liquids and creams that could provide a barrier to contracting HIV during sex."

Roger Pebody, treatment specialist for the HIV charity Terrence Higgins Trust said microbicides were one of the biggest hopes for preventing new HIV infections in the near future.

He said: "This is one of many projects that are in the early stages of development, however other microbicides could be as little as five years away."


061231
BB061230


Copyright © 2006 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.